Morel Rubinger

1.7k total citations
38 papers, 723 citations indexed

About

Morel Rubinger is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Morel Rubinger has authored 38 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 16 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Morel Rubinger's work include Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Neutropenia and Cancer Infections (8 papers). Morel Rubinger is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Neutropenia and Cancer Infections (8 papers). Morel Rubinger collaborates with scholars based in Canada, United States and Germany. Morel Rubinger's co-authors include Eric J. Bow, Brent Schacter, Tsiporah B. Shore, David Szwajcer, Mary Cheang, G. J. Williams, Christopher Bredeson, Matthew D. Seftel, A Demers and Regan Guilfoyle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Morel Rubinger

38 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morel Rubinger Canada 15 307 306 124 120 114 38 723
Şahika Zeynep Akı Türkiye 17 490 1.6× 285 0.9× 91 0.7× 141 1.2× 88 0.8× 71 895
Martin Mohren Germany 17 321 1.0× 188 0.6× 185 1.5× 91 0.8× 98 0.9× 37 936
Jyh‐Pyng Gau Taiwan 14 277 0.9× 158 0.5× 93 0.8× 105 0.9× 120 1.1× 74 659
Münci Yağcı Türkiye 15 391 1.3× 279 0.9× 124 1.0× 90 0.8× 163 1.4× 86 779
Ignacio Lorenzo Spain 17 685 2.2× 239 0.8× 99 0.8× 147 1.2× 183 1.6× 34 946
Kyu Bo Lee South Korea 15 348 1.1× 229 0.7× 121 1.0× 54 0.5× 111 1.0× 38 681
Éric Hermet France 12 240 0.8× 214 0.7× 92 0.7× 81 0.7× 46 0.4× 31 548
M. R. Nowrousian Germany 9 201 0.7× 252 0.8× 231 1.9× 82 0.7× 45 0.4× 20 701
Graham Jackson United States 10 412 1.3× 191 0.6× 70 0.6× 66 0.6× 233 2.0× 16 771
Xiaochun Zhu United States 12 509 1.7× 250 0.8× 147 1.2× 63 0.5× 69 0.6× 35 969

Countries citing papers authored by Morel Rubinger

Since Specialization
Citations

This map shows the geographic impact of Morel Rubinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morel Rubinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morel Rubinger more than expected).

Fields of papers citing papers by Morel Rubinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morel Rubinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morel Rubinger. The network helps show where Morel Rubinger may publish in the future.

Co-authorship network of co-authors of Morel Rubinger

This figure shows the co-authorship network connecting the top 25 collaborators of Morel Rubinger. A scholar is included among the top collaborators of Morel Rubinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morel Rubinger. Morel Rubinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubinger, Morel, et al.. (2013). Early Stage W.H.O. Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone. PLoS ONE. 8(6). e65156–e65156. 14 indexed citations
2.
Klewes, Ludger, Rhea U. Vallente, Amanda Guffei, et al.. (2013). Three-dimensional Nuclear Telomere Organization in Multiple Myeloma. Translational Oncology. 6(6). 749–IN36. 19 indexed citations
3.
Rubinger, Morel, et al.. (2011). If at first you don't succeed: Try, try again. American Journal of Hematology. 87(3). 295–297. 3 indexed citations
4.
Liu, Hongwei, Matthew D. Seftel, Morel Rubinger, et al.. (2010). Total Body Irradiation Compared With BEAM: Long-Term Outcomes of Peripheral Blood Autologous Stem Cell Transplantation for Non-Hodgkin's Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 78(2). 513–520. 12 indexed citations
5.
Paulson, Kristjan, David Szwajcer, Pascal Lambert, et al.. (2010). Incidence and Clinical Features of Acute Promyelocytic Leukemia In a Population-Based Canadian Cohort. Blood. 116(21). 4374–4374. 2 indexed citations
6.
Rubinger, Morel, David Lillicrap, Georges‐Étienne Rivard, et al.. (2008). A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. Haemophilia. 14(2). 281–286. 32 indexed citations
7.
Guilfoyle, Regan, A Demers, Christopher Bredeson, et al.. (2008). Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center. Bone Marrow Transplantation. 43(2). 133–139. 64 indexed citations
8.
Seftel, Matthew D. & Morel Rubinger. (2007). The role of hematopoietic stem cell transplantation in advanced Hodgkin Lymphoma. Transfusion and Apheresis Science. 37(1). 49–56. 3 indexed citations
9.
Ho, M., Deepak Pruthi, Morel Rubinger, et al.. (2007). High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation. Bone Marrow Transplantation. 40(11). 1049–1053. 13 indexed citations
10.
11.
Jassal, Davinder S., et al.. (2001). Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T‐cell lymphoma: Case study and review. American Journal of Hematology. 69(1). 64–66. 7 indexed citations
12.
Williams, G. J., Morel Rubinger, Norman M. Pettigrew, et al.. (1998). Expression of P53 Predicts Treatment Failure in Aggressive Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 29(1-2). 139–144. 25 indexed citations
13.
Bow, Eric J., et al.. (1997). Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults.. Journal of Clinical Oncology. 15(6). 2254–2261. 78 indexed citations
14.
Rubinger, Morel, et al.. (1997). In‐vitro stability of porcine factor VIII (Hyate:C®). Haemophilia. 3(1). 21–23. 4 indexed citations
15.
Rubinger, Morel, et al.. (1997). Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid. Annals of Pharmacotherapy. 31(1). 56–58. 25 indexed citations
16.
Daeninck, Paul, G. J. Williams, Morel Rubinger, & James B. Johnston. (1997). Multiple Myeloma Presenting Clinically as Lymphoma. Leukemia & lymphoma. 28(1-2). 195–201. 4 indexed citations
17.
Bow, Eric J., Jenny Sutherland, G. J. Williams, et al.. (1996). Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide.. Journal of Clinical Oncology. 14(4). 1345–1352. 39 indexed citations
18.
Rubinger, Morel, et al.. (1995). Metastatic Extraskeletal Myxoid Chondrosarcoma. CHEST Journal. 108(1). 281–282. 11 indexed citations
19.
OʼReilly, Sean, Karen A. Gelmon, N Onetto, et al.. (1993). Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil.. Journal of Clinical Oncology. 11(12). 2411–2416. 7 indexed citations
20.
Shepherd, Frances A., Robert J. Ginsberg, G. Alexander Patterson, et al.. (1991). Is there ever a role for salvage operations in limited small-cell lung cancer?. Journal of Thoracic and Cardiovascular Surgery. 101(2). 196–200. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şahika Zeynep Akı Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Jyh‐Pyng Gau Breakdown of academic impact, for papers by Münci Yağcı Breakdown of academic impact, for papers by Ignacio Lorenzo Breakdown of academic impact, for papers by Kyu Bo Lee Breakdown of academic impact, for papers by Éric Hermet Breakdown of academic impact, for papers by M. R. Nowrousian Breakdown of academic impact, for papers by Graham Jackson Breakdown of academic impact, for papers by Xiaochun Zhu
Rankless by CCL
2026